Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5266475
Max Phase: Preclinical
Molecular Formula: C23H18ClN5S
Molecular Weight: 431.95
Associated Items:
ID: ALA5266475
Max Phase: Preclinical
Molecular Formula: C23H18ClN5S
Molecular Weight: 431.95
Associated Items:
Canonical SMILES: Clc1cccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)c1
Standard InChI: InChI=1S/C23H18ClN5S/c24-18-4-3-5-19(14-18)29-22(16-8-11-25-12-9-16)27-28-23(29)30-13-10-17-15-26-21-7-2-1-6-20(17)21/h1-9,11-12,14-15,26H,10,13H2
Standard InChI Key: YULBUYBWADPSTL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 431.95 | Molecular Weight (Monoisotopic): 431.0971 | AlogP: 5.80 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.71 | CX LogP: 5.51 | CX LogD: 5.51 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.35 | Np Likeness Score: -1.93 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):